Complement promotes endothelial von Willebrand factor and angiopoietin-2 release in obstructive sleep apnea.
Ontology highlight
ABSTRACT: Obstructive sleep apnea (OSA) is highly prevalent and triples vascular thromboembolic risk. Intermittent hypoxia (IH) during transient cessation of breathing in OSA impairs endothelial protection against complement. Complement activation stimulates the endothelial release of a pro-thrombotic von Willebrand factor (vWF). We investigated whether increased complement activity in OSA promotes the endothelial release of vWF and pro-inflammatory angiopoietin-2. We further investigated whether improving complement protection with statins reverses these changes. Using endothelial cells (ECs) and blood collected from OSA patients (n = 109) and controls (n = 67), we assessed whether altered cellular localization of complement inhibitor CD59 in OSA modulates exocytosis of Weibel-Palade bodies (WPB),
SUBMITTER: Gao S
PROVIDER: S-EPMC8033461 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA